Your session is about to expire
← Back to Search
Behavioral Intervention
Algorithm-Based Strategies for Opioid Use Disorder
N/A
Waitlist Available
Led By Jessica Merlin
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test strategies to help people with chronic pain who are misusing opioids.
Who is the study for?
This trial is for individuals who are prescribed long-term opioid therapy (LTOT) for chronic pain and exhibit opioid misuse behaviors. Participants must be from UPMC community primary care practices. Those from non-UPMC practices cannot participate.Check my eligibility
What is being tested?
The study tests a new approach to reduce opioid misuse by implementing consensus-based algorithms in healthcare settings. It's part of the NIH HEAL initiative aimed at improving treatments for patients with opioid use issues on LTOT.See study design
What are the potential side effects?
Since this trial focuses on implementing treatment algorithms rather than testing drugs, it does not have direct side effects like medication would. However, changes in management may affect patient experience.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of algorithms
Feasibility of algorithms
Secondary outcome measures
Preliminary Effectiveness of algorithms
Trial Design
1Treatment groups
Experimental Treatment
Group I: Implementation bundleExperimental Treatment1 Intervention
Participating clinics will experience integration of the "Implementation Bundle" into their practices.
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,553 Total Patients Enrolled
16 Trials studying Opioid Abuse
338,788 Patients Enrolled for Opioid Abuse
University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,342,261 Total Patients Enrolled
Jessica MerlinPrincipal InvestigatorUniversity of Pittsburgh
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- This criterion excludes individuals who do not receive medical care from UPMC (University of Pittsburgh Medical Center) practices.
Research Study Groups:
This trial has the following groups:- Group 1: Implementation bundle
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants have been enrolled into the experiment thus far?
"Indeed. Per the information on clinicaltrials.gov, this clinical trial is actively enrolling 80 patients from a single site. Initially published in March 1st 2022 and updated as recently as April 6th 2022, the study has been open for some time now."
Answered by AI
Is this experiment currently recruiting participants?
"The enrollment period for this medical trial is still open, as evidenced on clinicaltrials.gov where it was first published on March 1st 2022 and most recently modified on April 6th of the same year."
Answered by AI
Share this study with friends
Copy Link
Messenger